MCVAC療法後に自家末梢血幹細胞移植を受けたDLBCL患者20人の後ろ向き分析

SEKIGUCHI Yasunobu; WAKABAYASHI Mutsumi; TAKIZAWA Haruko; IIZUKA Hiroko; SAKAJIRI Sakura; SUGIMOTO Keiji; INANO Tadaaki; FUKUDA Yasutaka; HAMANO Yasuharu; HIRANO Takao; SATO Eriko; ARITAKA Nanae; YAHATA Yuriko; MORITA Kimio; OKAMURA Takamitsu; TOMITA Shigeki; IZUMI Hiroshi; OKUBO Mitsuo; NAKAMURA Noriko; SAWADA Tomohiro; NOGUCHI Masaaki

文献

J-GLOBAL ID：201902222422347381 整理番号：19A1874354

MCVAC療法後に自家末梢血幹細胞移植を受けたDLBCL患者20人の後ろ向き分析

Retrospective Analysis of 20 Patients with DLBCL Who Received MCVAC Followed by Autologous Peripheral Blood Stem Cell Transplantation

出版者サイト {{ this.onShowPLink() }} 複写サービスで全文入手 {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=19A1874354&COPY=1") }}
高度な検索・分析はJDreamⅢで {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A1874354&from=J-GLOBAL&jstjournalNo=Z0938A") }}

著者 (21件)： , , , , , , , , , , , , , , , , , , , ,
資料名：
巻： 46 号： 8 ページ： 1265-1273 発行年： 2019年08月15日
JST資料番号： Z0938A ISSN： 0385-0684 資料種別：逐次刊行物 (A)
記事区分：原著論文発行国：日本 (JPN) 言語：英語 (EN)

若年者の化学療法に感受性のある再発もしくは初回治療不応性のa...

,...
,...

続きはJDreamIII（有料）にて {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A1874354&from=J-GLOBAL&jstjournalNo=Z0938A") }}

腫ようの薬物療法 , 血液の腫よう

, , ,

引用文献 (32件)：

Feugier P, Van Hoof A, Sebban C, et al: Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 23 (18) : 4117-4126, 2005.
Pfreundschuh M, Trümper L, Österborg A, et al: CHOP-like chemotherapy plus rituximab versus CHOP-like chemothera-py alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the Mab-Thera International Trial (MInT) Group. Lancet Oncol 7 (5) : 379-391, 2006.
Sehn LH, Donaldson J, Chhanabhai M, et al: Introduction of combined CHOP plus rituximab therapy dramatically im-proved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol 23 (22) : 5027-5033, 2005.
Kato J, Mori T, Yokoyama K, et al: Safety and efficacy of high-dose ranimustine, cytarabine, etoposide and CY (MCVAC) regimen followed by autologous peripheral blood stem cell transplantation for high-risk diffuse large B-cell lymphoma. Bone Marrow Transplant 46 (7) : 923-928, 2011.
Fisher RI, Gaynor ER, Dahlberg S, et al: Comparison of a standard regimen (CHOP) with three intensive chemothera-py regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328 (14) : 1002-1006, 1993.

, , ,

前のページに戻る